This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps
Nature Communications Open Access 18 March 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Leslie, J. et al. CXCR2 inhibition enables NASH-HCC immunotherapy. Gut https://doi.org/10.1136/gutjnl-2021-326259 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kotsiliti, E. CXCR2 inhibition in NASH-HCC. Nat Rev Gastroenterol Hepatol 19, 415 (2022). https://doi.org/10.1038/s41575-022-00637-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-022-00637-3